This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heartattack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.
milla1cf Wed, 03/06/2024 - 18:48 March 6, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ) for its Coronary Artery Disease ( CAD ) Staging System.
Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. fold higher risk for cardiac mortality and 5.5-fold
A projected rise in heart disease and stroke – along with several key riskfactors, including high blood pressure and obesity – is likely to triple related costs to $1.8 christine.book Tue, 06/18/2024 - 11:22 June 18, 2024 — At least 6 in 10 adults in an older, more diverse U.S. of the population.
milla1cf Sun, 04/07/2024 - 18:20 April 7, 2024 — An estimated 1 in 5 U.S. adults—and more than 2 in 5 adults aged 60 years and older—have elevated triglycerides, also known as hypertriglyceridemia , putting them at an increased risk for heartattacks and stroke. and Canada.
Circulation, Volume 150, Issue Suppl_1 , Page A4140513-A4140513, November 12, 2024. Aims:Asian Americans experience disproportionate burdens of cardiovascular riskfactors and cardiovascular disease (CVD). However, the trends in cardiovascular risks in adults from different Asian ethnic backgrounds remain understudied.
tim.hodson Fri, 10/04/2024 - 11:39 Oct. 2, 2024 — Eko Health recently announced a new independent study from researchers at Imperial College London (Imperial) that demonstrated how AI can identify patients with significantly higher risk of experiencing major adverse cardiac events (MACE), including heartattacks and heart failure.
High levels of triglycerides and the lipid particles on which they are carried in the blood can contribute to the formation of “plaques” in the arteries that impede blood flow and can lead to heartattacks and strokes. A total of 229 patients (average age 55 years, 78% men and 90% White) were enrolled in the trial in eight countries.
Background:The STRACK project aims to improve post-stroke patient management and the transition from acute to primary care thanks to improvements in patient pathways and monitoring cardiovascular riskfactors: heart failure, diabetes, atrial fibrillation, dyslipidemia and hypertension.
When it comes to cardiovascular disease, two of the biggest riskfactors we must consider are: ApoB concentration - A measure of the number of circulating lipid particles. Visceral Fat & Insulin Resistance - The amount of fat in your abdominal cavity and major organs and how it influences your risk of insulin resistance.
Elevated levels of Lp(a) are an independent and causal riskfactor for atherosclerotic cardiovascular diseases through mechanisms associated with increased atherogenesis, inflammation, and thrombosis. Having elevated Lp(a) can increase risk of heartattack, stroke, and peripheral artery disease.It
This was one of my main research interests in graduate school when I was involved in projects related to the effects of sleep deprivation on blood vessel function (endothelial function)—a major riskfactor for developing cardiovascular disease. Am J Physiol Heart Circ Physiol. 2024 Jan 1;326(1):H291-H301.
However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heartattack. The study enrolled 6,522 people treated for acute myocardial infarction at 451 centers in 22 countries. About 32% had Type 2 diabetes.
milla1cf Wed, 04/24/2024 - 19:01 April 24, 2024 — Hello Heart , a digital leader in preventive heart health, today announced results from its latest study observing the benefits of scalable, accessible digital health tools for a growing senior population. Eighty percent of heartattacks and strokes are preventable.
While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heartattack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,
milla1cf Sat, 04/06/2024 - 18:32 April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heartattack or stroke within three months of a prior heartattack, according to research presented at the American College of Cardiology ’s Annual Scientific Session.
The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heartattack or stroke within three months of a prior heartattack, according to research presented at ACC.24, 24, the American College of Cardiology Annual Annual Scientific Session.
The findings – published this week in the Journal of the American College of Cardiology — could fuel advocacy for a paradigm shift in clinical heart health guidelines to address cardiovascular riskfactors at an earlier age in childhood cancer survivors. “We
Elucid’s PlaqueIQ is the first and only histology-validated FDA-cleared software to non-invasively quantify and characterize non-calcified plaque and its components such as lipid-rich necrotic core (LRNC), giving potential insights into high-risk plaques, key drivers of risk of heartattack and stroke.
tim.hodson Wed, 08/21/2024 - 11:32 Aug. 21, 2024 — The incidence rate of heart failure was 2- to 3-fold higher among American Indian populations than rates observed in studies focused on other population groups, such as African American, Hispanic or white adults, in a new study published in the Journal of the American Heart Association.
These new findings suggest that people with high-risk plaques that are likely to rupture could benefit from the procedure as a pre-emptive measure rather than waiting for a heartattack or other severe reduction in blood flow to occur. years (maximum up to 7.9
Kenneth Chan, MBBS, Academic Clinical Research Fellow in the Division of Cardiovascular Medicine at Oxford University Hospitals (UK) will receive the 2024 SCCT Clinical Trials and Registries Award (CTRA) at the opening session of the Society’s 19th Annual Scientific Meeting (SCCT2024) on Friday, July 19 in Washington, DC.
mtaschetta-millane Fri, 02/16/2024 - 09:40 February 16, 2024 — Cardio Diagnostics Holdings, Inc. , HeartRisk's ability to aggregate population-level heartattackrisk, the presence of heart disease detection, and intervention monitoring and management aligns with the financial incentives of shared-risk contracts.
The answer is pretty simple, but most people get this wrong, and doing so increases their future risk of heartattack and strokes. The problem is that high blood pressure is not some obscure risk that only impacts a small percentage of the population. 2024 Nov;81(11):2329-2339. It is not enough. N Engl J Med.
Zerlasiran is a siRNA (short interfering RNA) designed to lower the body’s production of Lp(a), a key genetic riskfactor for cardiovascular disease affecting up to 20% of the world’s population. In this case, it aims to ‘silence’ LPA, a gene that tells the body to make a specific protein that is only found in Lp(a).
3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heartattack or myocardial infarction (MI), stroke, and cardiovascular (CV) death.4 21 Luckily, each of these risks can be measured by simple blood tests. 4 In the U.S. 22 In general, hsCRP values above 2.0
Getty Images milla1cf Thu, 01/25/2024 - 20:44 January 25, 2024 — Agepha Pharma , a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment ( LODOCO – colchicine, 0.5 mg tablets for therapeutic intervention. In June 2023, the U.S.
milla1cf Fri, 01/19/2024 - 10:55 January 19, 2024 — Orchestra BioMed , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the first patient was randomized in the BACKBEAT pivotal study in late December 2023. Suman Pasupuleti, M.D. and Europe.
Circulation, Volume 150, Issue Suppl_1 , Page A4139303-A4139303, November 12, 2024. For ME immigrants, no significant changes were observed over time for most riskfactors (p>0.05).
Our findings show that interventions based on techniques from behavioral economics can achieve and sustain increased levels of physical activity in a population with riskfactors for cardiovascular disease and could be another tool to help reduce cardiovascular risk.”
A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heartattack, stroke and death for people with Peripheral Artery Disease (PAD).
Getty Images milla1cf Thu, 06/06/2024 - 21:40 June 6, 2024 — A substantial portion of young athletes are at risk of hypertension, according to a study presented at the American College of Cardiology’s Care of the Athletic Heart conference , taking place on June 6-8 in Washington. according to CardioSmart.org.
milla1cf Wed, 03/13/2024 - 16:52 March 13, 2024 — In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.
Clinicians currently use two separate risk models to assess patients’ chances of having heartattacks , strokes , and other major cardiovascular events. We therefore wondered if a single set of predictors, based on traditional primary-prevention riskfactors, could be used for both primary and secondary prevention,” Mok says.
Heart disease remains the leading cause of death for men and women. 80% of heartattacks and strokes linked to CVD are preventable with optimal riskfactor management. However, every 40 seconds, an individual in the US suffers a heartattack. What are we falling short?
A new peer-reviewed study published in the Journal of the American Heart Association , JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight.
Circulation, Volume 150, Issue Suppl_1 , Page A4141288-A4141288, November 12, 2024. Introduction:Cardiometabolic diseases significantly increase the risk of stroke and heartattack, leading causes of death worldwide. e-therapeutics (ETX) uniquely combines computation and RNAi to discover life-transforming medicines.
tim.hodson Wed, 10/23/2024 - 13:54 Oct. According to a recent survey released today by the Society, nearly one in three Americans at the highest risk for developing blood vessel (vascular) diseases have not heard of any of the most common conditions, like peripheral artery disease and carotid artery disease.
Circulation, Volume 150, Issue Suppl_1 , Page A4125581-A4125581, November 12, 2024. Premature ASCVD status was determined by interviews conducted at enrollment, encompassing a self-reported composite disease history of coronary heart disease, angina pectoris, heartattack, and stroke.
Getty Images milla1cf Tue, 03/05/2024 - 13:15 March 5, 2024 — Frequent cannabis smoking may significantly increase a person’s risk for heartattack and stroke, according to an observational study supported by the National Institutes of Health. states and two territories.
But remember, heart disease or atherosclerosis does not kill people. Heartattacks kill people. A heartattack occurs when plaque in your coronary artery ruptures and causes a clot to form, which stops blood flow to the heart muscle, causing it to die. Now, we have a risk that seems worrying.
Ella Ishaaya, MD milla1cf Tue, 04/02/2024 - 18:32 April 2, 2024 — A woman’s cardiovascular risk can rise sharply after she goes through menopause, quickly catching up to men of a similar age and health profile, according to new findings presented at the American College of Cardiology’s Annual Scientific Session. In the U.S.
Getty Images milla1cf Fri, 03/08/2024 - 14:35 March 8, 2024 — Novo Nordisk today announced that the U.S. mg significantly reduced the risk for first occurrence of a three-part composite MACE endpoint consisting of cardiovascular death, non-fatal heartattack, or non-fatal stroke. 2 Wegovy 2.4 with placebo.
With that in mind, let's see what the research says about supplements and heart health. A recent systematic review and meta-analysis examined a range of commonly used supplements and whether they improved cardiovascular riskfactors like blood pressure and cardiovascular events such as heartattacks and stroke.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content